4ddf57b18582fcb1fe0c355dda29d107  286870.pdf
c3f785d7f4ff1e1244f694e803cde1e76bbd46e1  286870.pdf
80b9f80007ae34586eb0d0768645462f72efccea7dd5929d7cb6a33378516b83  286870.pdf

Title:          Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: a cross-trial comparison of phase 3 studies: Ibrutinib compared with chemoimmunotherapy for treatment-naïve CLL
CreationDate:   Sat Oct 20 03:43:05 2018 CEST
ModDate:        Sat Oct 20 03:43:05 2018 CEST
Tagged:         no
UserProperties: no
Suspects:       no
Form:           AcroForm
JavaScript:     no
Pages:          9
Encrypted:      no
Page size:      595.276 x 782.362 pts
Page rot:       0
File size:      1350871 bytes
Optimized:      yes
PDF version:    1.7


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
BOFOCN+AdvTTfac587ca.B               Type 1C           WinAnsi          yes yes no     170  0
BOFOCO+AdvTT6071803a.B               Type 1C           WinAnsi          yes yes no     171  0
BOFOEO+AdvTTa9c1b374                 Type 1C           WinAnsi          yes yes no     172  0
BOFOFP+AdvTTa9c1b374+22              Type 1C           Custom           yes yes yes    173  0
BOFPJI+AdvTTeb5f0e55.I               Type 1C           WinAnsi          yes yes no     185  0
BOFPJJ+AdvTTa9c1b374+20              Type 1C           WinAnsi          yes yes no     186  0
BOGAAH+AdvOT8608a8d1+03              Type 1C           Custom           yes yes yes     20  0
BOGAKF+HelveticaLTStd-Roman          Type 1C           Custom           yes yes yes     87  0
BOGALF+HelveticaLTStd-Bold           Type 1C           WinAnsi          yes yes no      86  0
BOGBDD+AdvTT9c438aa4.BI              Type 1C           WinAnsi          yes yes no      94  0
BOGBLB+STIXGeneral-Regular           Type 1C           Custom           yes yes yes     53  0
BOGBLC+HelveticaLTStd-BoldObl        Type 1C           WinAnsi          yes yes no      52  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2024-01-12 02:33:43 CET
 RepresentationInformation: 286870.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2024-01-11 13:58:27 CET
  Size: 1350871
  Format: PDF
  Version: 1.7
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 195
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseNone
    Outlines: 
     Item: 
      Title:  Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: ...
      Destination: atl_AJH_25259_
      Children: 
       Item: 
        Title: 1  INTRODUCTION
        Destination: HeadingAJH_25259ajh25259-sec-0001
       Item: 
        Title: 2  METHODS
        Destination: HeadingAJH_25259ajh25259-sec-0002
        Children: 
         Item: 
          Title: 2.1  Procedures
          Destination: HeadingAJH_25259ajh25259-sec-0003
         Item: 
          Title: 2.2  Statistical analysis
          Destination: HeadingAJH_25259ajh25259-sec-0004
       Item: 
        Title: 3  RESULTS
        Destination: HeadingAJH_25259ajh25259-sec-0005
       Item: 
        Title: 4  DISCUSSION
        Destination: HeadingAJH_25259ajh25259-sec-0006
       Item: 
        Title: 4  ACKNOWLEDGMENTS
        Destination: HeadingAJH_25259ajh25259-sec-0007
       Item: 
        Title:   CONFLICT OF INTEREST
        Destination: HeadingAJH_25259ajh25259-sec-0008
       Item: 
        Title:   AUTHOR CONTRIBUTIONS
        Destination: HeadingAJH_25259ajh25259-sec-0009
       Item: 
        Title:   REFERENCES
        Destination: HeadingAJH_25259ajh25259-bibl-00011
   Info: 
    Title: Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: a cross-trial comparison of phase 3 studies: Ibrutinib compared with chemoimmunotherapy for treatment-naïve CLL
    CreationDate: Sat Oct 20 04:13:05 CEST 2018
    ModDate: Sat Oct 20 04:13:05 CEST 2018
   ID: 0xd65ab9d84ad382e8f8e2069e5febbe5d, 0x7cf7d34626b0ce085c58517477b61230
   Filters: 
    FilterPipeline: FlateDecode
   Fonts: 
    Type1: 
     Font: 
      BaseFont: BOGAAH+AdvOT8608a8d1+03
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: BOGAAH+AdvOT8608a8d1+03
       Flags: Symbolic
       FontBBox: -479, -364, 854, 927
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: BOGBLC+HelveticaLTStd-BoldObl
      FontSubset: true
      FirstChar: 32
      LastChar: 86
      FontDescriptor: 
       FontName: BOGBLC+HelveticaLTStd-BoldObl
       Flags: Nonsymbolic, Italic, ForceBold
       FontBBox: -174, -228, 1114, 962
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: BOGBLB+STIXGeneral-Regular
      FontSubset: true
      FirstChar: 2
      LastChar: 60
      FontDescriptor: 
       FontName: BOGBLB+STIXGeneral-Regular
       Flags: Symbolic
       FontBBox: 54, -217, 629, 683
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: BOGALF+HelveticaLTStd-Bold
      FontSubset: true
      FirstChar: 32
      LastChar: 122
      FontDescriptor: 
       FontName: BOGALF+HelveticaLTStd-Bold
       Flags: Nonsymbolic, ForceBold
       FontBBox: -170, -228, 1003, 962
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: BOGAKF+HelveticaLTStd-Roman
      FontSubset: true
      FirstChar: 2
      LastChar: 121
      FontDescriptor: 
       FontName: BOGAKF+HelveticaLTStd-Roman
       Flags: Symbolic
       FontBBox: -166, -225, 1000, 931
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: BOFPJI+AdvTTeb5f0e55.I
      FontSubset: true
      FirstChar: 46
      LastChar: 122
      FontDescriptor: 
       FontName: BOFPJI+AdvTTeb5f0e55.I
       Flags: Nonsymbolic
       FontBBox: -83, -177, 989, 927
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: BOFPJJ+AdvTTa9c1b374+20
      FontSubset: true
      FirstChar: 150
      LastChar: 151
      FontDescriptor: 
       FontName: BOFPJJ+AdvTTa9c1b374+20
       Flags: Nonsymbolic
       FontBBox: -239, -218, 1166, 937
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: BOFOCN+AdvTTfac587ca.B
      FontSubset: true
      FirstChar: 49
      LastChar: 85
      FontDescriptor: 
       FontName: BOFOCN+AdvTTfac587ca.B
       Flags: Nonsymbolic
       FontBBox: -72, -177, 1062, 958
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: BOFOCO+AdvTT6071803a.B
      FontSubset: true
      FirstChar: 37
      LastChar: 239
      FontDescriptor: 
       FontName: BOFOCO+AdvTT6071803a.B
       Flags: Nonsymbolic
       FontBBox: -52, -177, 1041, 947
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: BOFOEO+AdvTTa9c1b374
      FontSubset: true
      FirstChar: 37
      LastChar: 239
      FontDescriptor: 
       FontName: BOFOEO+AdvTTa9c1b374
       Flags: Nonsymbolic
       FontBBox: -41, -177, 1010, 927
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: BOFOFP+AdvTTa9c1b374+22
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: BOFOFP+AdvTTa9c1b374+22
       Flags: Symbolic
       FontBBox: 0, -166, 677, 854
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: BOGBDD+AdvTT9c438aa4.BI
      FontSubset: true
      FirstChar: 110
      LastChar: 110
      FontDescriptor: 
       FontName: BOGBDD+AdvTT9c438aa4.BI
       Flags: Nonsymbolic
       FontBBox: -83, -177, 1010, 947
       FontFile3: true
      Encoding: WinAnsiEncoding
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 5.4-c006 80.159825, 2016/09/16-03:31:08        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:jav="http://www.niso.org/schemas/jav/1.0/"
            xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/"
            xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/"
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/">
         <jav:journal_article_version>VoR</jav:journal_article_version>
         <prism:doi>10.1002/ajh.25259</prism:doi>
         <pdfx:WPS-ARTICLEDOI>10.1002/ajh.25259</pdfx:WPS-ARTICLEDOI>
         <pdfx:WPS-JOURNALDOI>10.1002/(ISSN)1096-8652</pdfx:WPS-JOURNALDOI>
         <pdfx:WPS-PROCLEVEL>3</pdfx:WPS-PROCLEVEL>
         <dc:format>application/pdf</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: a cross-trial comparison of phase 3 studies: Ibrutinib compared with chemoimmunotherapy for treatment-naïve CLL</rdf:li>
            </rdf:Alt>
         </dc:title>
         <xmp:ModifyDate>2018-10-20T07:13:05+05:30</xmp:ModifyDate>
         <xmp:CreateDate>2018-10-20T07:13:05+05:30</xmp:CreateDate>
         <xmp:MetadataDate>2018-10-20T07:13:05+05:30</xmp:MetadataDate>
         <xmpMM:DocumentID>uuid:030437ef-3015-476a-a6ba-737de7050bd6</xmpMM:DocumentID>
         <xmpMM:InstanceID>uuid:217f88ba-4852-4cd6-9146-776b41710b13</xmpMM:InstanceID>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1402
     Sequence: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 133, 581, 142, 589
      Annotation: 
       Subtype: Link
       Rect: 65, 99, 148, 106
      Annotation: 
       Subtype: Link
       Rect: 205, 50, 382, 57
      Annotation: 
       Subtype: Link
       Rect: 76, 18, 181, 25
    Page: 
     Label: 1403
     Sequence: 2
    Page: 
     Label: 1404
     Sequence: 3
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 489, 425, 547, 433
    Page: 
     Label: 1405
     Sequence: 4
    Page: 
     Label: 1406
     Sequence: 5
    Page: 
     Label: 1407
     Sequence: 6
    Page: 
     Label: 1408
     Sequence: 7
    Page: 
     Label: 1409
     Sequence: 8
    Page: 
     Label: 1410
     Sequence: 9
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 96, 709, 105, 718
      Annotation: 
       Subtype: Link
       Rect: 107, 708, 246, 716
      Annotation: 
       Subtype: Link
       Rect: 213, 600, 288, 608
      Annotation: 
       Subtype: Link
       Rect: 59, 590, 195, 598
      Annotation: 
       Subtype: Link
       Rect: 59, 580, 169, 588
      Annotation: 
       Subtype: Link
       Rect: 59, 570, 187, 578
      Annotation: 
       Subtype: Link
       Rect: 437, 229, 536, 237
      Annotation: 
       Subtype: Link
       Rect: 319, 216, 342, 224
  Checksum: b4d5eeec
   Type: CRC32
  Checksum: 4ddf57b18582fcb1fe0c355dda29d107
   Type: MD5
  Checksum: c3f785d7f4ff1e1244f694e803cde1e76bbd46e1
   Type: SHA-1
  Checksum: 80b9f80007ae34586eb0d0768645462f72efccea7dd5929d7cb6a33378516b83
   Type: SHA-256